Aisha Elsayed Abdulla

Suggest Changes
  • Citations Per Year
Learn More
Despite extensive use, to the best of our knowledge, no trial has simultaneously compared the three currently used erythropoietin-stimulating agents (ESAs) in a prospective manner in the treatment of(More)
  • 1